A switch from CD44+ cell to EMT cell drives the metastasis of prostate cancer-Reference-Cited by-同舟云学术

A switch from CD44+ cell to EMT cell drives the metastasis of prostate cancer

Published:2014-11-25 Issue:2 Volume:6 Page:1202-1216
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Shang Zhiqun¹,Cai Qiliang¹,Zhang Minghao¹,Zhu Shimiao¹,Ma Yuan¹¹,Sun Libin¹,Jiang Ning¹,Tian Jing¹,Niu Xiaodan²,Chen Jiatong³,Sun Yinghao⁴,Niu Yuanjie¹

Affiliation:

1. Sex Hormone Research Center, Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, China

2. University of Rochester, Rochester, New York, USA

3. Department of Biochemistry and Molecular Biology, College of Life Sciences, Nankai university, Tianjin, China

4. Department of Urology, Changhai Hospital of the Second Military Medical University, Shanghai, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular heterogeneity in prostate cancer and the role of targeted therapy;Life Sciences;2024-01

2. The Pattern of Epithelial Carcinogenesis;Interdisciplinary Cancer Research;2024

3. A Narrative Review on CD44’s Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence;Cancers;2023-10-09

4. Pretreatment of prostate cancer cells with salinomycin and Wnt inhibitor increases the efficacy of cabazitaxel by inducing apoptosis and decreasing cancer stem cells;Medical Oncology;2023-06-01

5. The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis;International Journal of Biological Sciences;2023